Daniel L. Abravanel, Ph.D. - Publications

Affiliations: 
2013 Cell and Molecular Biology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Cell Biology, Oncology

5/9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Gómez Tejeda Zañudo J, Barroso-Sousa R, Jain E, Jin Q, Li T, Buendia-Buendia JE, Pereslete A, Abravanel DL, Ferreira AR, Wrabel E, Helvie K, Hughes ME, Partridge AH, Overmoyer B, Lin NU, et al. Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nature Communications. 15: 2446. PMID 38503755 DOI: 10.1038/s41467-024-45835-6  0.342
2015 Abravanel DL, Belka GK, Pan TC, Pant DK, Collins MA, Sterner CJ, Chodosh LA. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy. The Journal of Clinical Investigation. 125: 2484-96. PMID 25961456 DOI: 10.1172/Jci74883  0.639
2015 Abravanel DL, Collins MA, Belka GK, Pan T, Pant DK, Sterner CJ, Chodosh LA. Abstract 2894: Notch signaling promotes survival and recurrence of dormant mammary tumor cells following HER2/neu targeted therapy Cancer Research. 75: 2894-2894. DOI: 10.1158/1538-7445.Am2015-2894  0.639
2012 Abravanel DL, Sterner CJ, Pan T, Belka GK, Chodosh LA. Abstract A32: Notch signaling regulates recurrence in a model of HER2 targeted therapy Clinical Cancer Research. 18: A32-A32. DOI: 10.1158/1078-0432.Mechres-A32  0.634
2009 Plentz R, Park JS, Rhim AD, Abravanel D, Hezel AF, Sharma SV, Gurumurthy S, Deshpande V, Kenific C, Settleman J, Majumder PK, Stanger BZ, Bardeesy N. Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma. Gastroenterology. 136: 1741-9.e6. PMID 19208345 DOI: 10.1053/J.Gastro.2009.01.008  0.447
Low-probability matches (unlikely to be authored by this person)
2021 Alon S, Goodwin DR, Sinha A, Wassie AT, Chen F, Daugharthy ER, Bando Y, Kajita A, Xue AG, Marrett K, Prior R, Cui Y, Payne AC, Yao CC, Suk HJ, ... ... Abravanel DL, et al. Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems. Science (New York, N.Y.). 371. PMID 33509999 DOI: 10.1126/science.aax2656  0.257
2008 Rodriguez-Diaz A, Toyama Y, Abravanel DL, Wiemann JM, Wells AR, Tulu US, Edwards GS, Kiehart DP. Actomyosin purse strings: renewable resources that make morphogenesis robust and resilient. Hfsp Journal. 2: 220-37. PMID 19404432 DOI: 10.2976/1.2955565  0.249
2023 Comiter C, Vaishnav ED, Ciampricotti M, Li B, Yang Y, Rodig SJ, Turner M, Pfaff KL, Jané-Valbuena J, Slyper M, Waldman J, Vigneau S, Wu J, Blosser TR, Segerstolpe Å, ... Abravanel D, et al. Inference of single cell profiles from histology stains with the Single-Cell omics from Histology Analysis Framework (SCHAF). Biorxiv : the Preprint Server For Biology. PMID 36993643 DOI: 10.1101/2023.03.21.533680  0.23
2018 Abravanel DL, Nishino M, Sholl LM, Ambrogio C, Awad MM. An acquired NRAS Q61K mutation in BRAF V600E-mutant lung adenocarcinoma resistant to dabrafenib plus trametinib. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29631033 DOI: 10.1016/J.Jtho.2018.03.026  0.024
Hide low-probability matches.